LGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia. Research, Society and Development, [S. l.], v. 9, n. 9, p. e442997314, 2020. DOI: 10.33448/rsd-v9i9.7314. Disponível em: https://rsdjournal.org/rsd/article/view/7314. Acesso em: 5 dec. 2025.